← 產業報告目錄
Nucleic Acid Aptamers Market Size, Share & Trends Analysis Report By Type (DNA Aptamer, RNA Aptamer, XNA Aptamer), By Application (Drug Delivery, Anti-viral Therapy, Pathogen Recognition, Disease Recognition, Stem Cell Markers, Others), By Indication (Viral Infection, Cancer, Ophthalmology, Others), By End-User, By Region, And By Segment Forecasts, 2024-2031.
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-03-10頁數 180報告編號 INSIGHTACE-46e9b55527
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
In 2023, the Nucleic Acid Aptamers Market worldwide was assessed at USD 217.3 Mn. Analysts project it will progress to USD 732.5 Mn by 2031, at a CAGR of 16.7% spanning 2024 to 2031.
Nucleic Acid Aptamers encompasses concise, individual strands of dna or rna that have a strong affinity for certain targets, such as proteins or tiny molecules. The sector has gained traction as organizations seek innovative approaches to address evolving healthcare challenges.
Growth is supported by a convergence of factors: rising awareness among end users, continuous product innovation, and the mounting emphasis on efficiency and sustainability within the healthcare sector.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region forecasted to deliver the strongest growth trajectory through the forecast period, supported by demographic shifts and policy support.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Nucleic Acid Aptamers Market Snapshot
Chapter 4. Global Nucleic Acid Aptamers Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Type Estimates & Trend Analysis
5.1. By Type & Market Share, 2023 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Type:
5.2.1. DNA Aptamer
5.2.2. RNA Aptamer
5.2.3. XNA Aptamer
Chapter 6. Market Segmentation 2: By Application Estimates & Trend Analysis
6.1. By Application & Market Share, 2023 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Application:
6.2.1. Drug Delivery
6.2.2. Anti-viral Therapy
6.2.3. Pathogen Recognition
6.2.4. Disease Recognition
6.2.5. Stem Cell Markers
6.2.6. Others
Chapter 7. Market Segmentation 3: By Indication Estimates & Trend Analysis
7.1. By Indication & Market Share, 2023 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Indication:
7.2.1. Viral Infection
7.2.2. Cancer
7.2.3. Ophthalmology
7.2.4. Others
Chapter 8. Market Segmentation 4: by End User Estimates & Trend Analysis
8.1. by End User & Market Share, 2023 & 2031
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by End User:
8.2.1. Biopharmaceutical Companies
8.2.2. Diagnostic Centers
8.2.3. CROs
8.2.4. Others
Chapter 9. Nucleic Acid Aptamers Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Nucleic Acid Aptamers Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
9.1.2. North America Nucleic Acid Aptamers Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
9.1.3. North America Nucleic Acid Aptamers Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
9.1.4. North America Nucleic Acid Aptamers Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2024-2031
9.1.5. North America Nucleic Acid Aptamers Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
9.2. Europe
9.2.1. Europe Nucleic Acid Aptamers Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
9.2.2. Europe Nucleic Acid Aptamers Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
9.2.3. Europe Nucleic Acid Aptamers Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
9.2.4. Europe Nucleic Acid Aptamers Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2024-2031
9.2.5. Europe Nucleic Acid Aptamers Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
9.3. Asia Pacific
9.3.1. Asia Pacific Nucleic Acid Aptamers Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
9.3.2. Asia Pacific Nucleic Acid Aptamers Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
9.3.3. Asia Pacific Nucleic Acid Aptamers Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
9.3.4. Asia Pacific Nucleic Acid Aptamers Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2024-2031
9.3.5. Asia Pacific Nucleic Acid Aptamers Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
9.4. Latin America
9.4.1. Asia Pacific Nucleic Acid Aptamers Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
9.4.2. Asia Pacific Nucleic Acid Aptamers Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
9.4.3. Latin America Nucleic Acid Aptamers Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
9.4.4. Latin America Nucleic Acid Aptamers Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2024-2031
9.4.5. Latin America Nucleic Acid Aptamers Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
9.5. Middle East & Africa
9.5.1. Middle East & Africa Nucleic Acid Aptamers Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
9.5.2. Middle East & Africa Nucleic Acid Aptamers Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
9.5.3. Middle East & Africa Nucleic Acid Aptamers Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
9.5.4. Middle East & Africa Nucleic Acid Aptamers Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2024-2031
9.5.5. Middle East & Africa Nucleic Acid Aptamers Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Aptagen Labs
10.2.2. Aptamer Group
10.2.3. Base Pair Biotechnologies
10.2.4. NeoVentures Biotechnology Inc.
10.2.5. Aptamer Sciences, Inc.
10.2.6. SomaLogic Operating Co., Inc.
10.2.7. AptaTargets SL.
10.2.8. Aptus Biotech S.L.
10.2.9. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們